Ocular Therapeutix Total Current Liabilities 2011-2026 | OCUL

Annual Total Current Liabilities Ocular Therapeutix

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
50.8 M	41.4 M	34.9 M	31.4 M	26.3 M	26.7 M	12 M	9.16 M	13.4 M	8.3 M	5.38 M	5.87 M	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
50.8 M	5.38 M	22.1 M

Total Current Liabilities of other stocks in the Biotechnology industry

Issuer	Total Current Liabilities	Price	% 24h	Market Cap	Country
Aquestive Therapeutics AQST	47.6 M	$ 4.12	-0.36 %	$ 441 M	USA
Arcturus Therapeutics Holdings ARCT	36.4 M	$ 8.32	3.67 %	$ 228 M	Israel
Arcutis Biotherapeutics ARQT	130 M	$ 23.65	0.08 %	$ 3.01 B	USA
BioVie BIVI	2.27 M	$ 1.46	2.82 %	$ 2.16 M	USA
I-Mab IMAB	576 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	1.62 B	-	-	$ 40.3 B	USA
BioXcel Therapeutics BTAI	53.9 M	$ 1.16	-2.12 %	$ 14.2 M	USA
EyeGate Pharmaceuticals, Inc. EYEG	1.77 M	-	-1.52 %	$ 24.7 M	USA
Acorda Therapeutics ACOR	228 M	-	-24.86 %	$ 820 K	USA
Cabaletta Bio CABA	50.2 M	$ 3.1	4.56 %	$ 311 M	USA
Adverum Biotechnologies ADVM	22.9 M	-	-	$ 86.2 M	USA
Can-Fite BioPharma Ltd. CANF	2.05 M	$ 3.17	1.44 %	$ 6.9 B	Israel
Advaxis ADXS	25 M	-	-9.65 %	$ 45.9 M	USA
Applied Molecular Transport AMTI	15.1 M	-	-	$ 10.1 M	USA
AgeX Therapeutics AGE	3.56 M	-	-10.17 %	$ 12.2 K	USA
AIkido Pharma AIKI	1.61 M	-	1.93 %	$ 17.4 M	USA
Aeglea BioTherapeutics AGLE	58.7 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	25.2 M	-	-	$ 26.5 M	USA
Akero Therapeutics AKRO	39.8 M	-	-	$ 3.67 B	USA
Akouos AKUS	16.8 M	-	0.23 %	$ 488 M	USA
Catalyst Biosciences CBIO	18.3 M	$ 19.48	0.39 %	$ 1.74 B	USA
Институт стволовых клеток человека ISKJ	556 M	-	-	-	Russia
Allena Pharmaceuticals ALNA	15.7 M	-	3.16 %	$ 1.9 M	USA
Codexis CDXS	25.3 M	$ 1.95	6.87 %	$ 170 M	USA
Alpine Immune Sciences ALPN	58 M	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	6.18 M	-	10.36 %	$ 9.8 M	USA
Anavex Life Sciences Corp. AVXL	5.04 M	$ 3.01	0.67 %	$ 257 M	USA
Cerus Corporation CERS	101 M	$ 1.91	2.69 %	$ 364 M	USA
Cullinan Management CGEM	37.7 M	$ 15.11	4.71 %	$ 910 M	USA
Coherus BioSciences CHRS	140 M	$ 1.72	-0.87 %	$ 201 M	USA
CollPlant Biotechnologies Ltd. CLGN	2.97 M	$ 0.46	-13.02 %	$ 5.27 M	Israel
Aravive ARAV	22.1 M	-	-13.39 %	$ 1.45 M	USA
Aptose Biosciences APTO	9.31 M	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	6.29 M	-	-39.0 %	$ 4.57 M	USA
CNS Pharmaceuticals CNSP	4.1 M	$ 2.25	-0.44 %	$ 998 K	USA
Catalyst Pharmaceuticals CPRX	147 M	$ 24.95	1.05 %	$ 3.05 B	USA
Celldex Therapeutics CLDX	51 M	$ 31.33	0.85 %	$ 2.08 B	USA
Corbus Pharmaceuticals Holdings CRBP	20.7 M	$ 10.27	0.98 %	$ 137 M	USA
Cardiff Oncology CRDF	16.4 M	$ 1.6	1.27 %	$ 107 M	USA
Avenue Therapeutics ATXI	1.1 M	-	-52.27 %	$ 4.45 M	USA